Anti-VEGF therapy is effective for neovascular age-related macular degeneration (AMD); however, there are patients who fail to respond to monotherapy alone. Angiogenesis is a complex process that ...

Long-term follow-up continues, and the pivotal trials for neovascular AMD are ongoing. For subretinal administration, a phase 2 pharmacodynamic trial is ongoing. In addition, two phase 2 trials ...

Larsen: Early detection is important when it comes to neovascular (or wet) age-related macular degeneration (AMD). There are ...

Background: To identify differences between Ranibizumab and Aflibercept in treatment-naïve patients with neovascular age-related macular degeneration (nvAMD) in a real-life clinical setting.